High-precision leukocyte-depleted filtering membrane and preparation method thereof
Through electrospinning technology of chitosan and polybutylene terephthalate, high-precision deletion leukocyte filtration membrane with uniform pore size, hydrophilicity and antibacteriality were prepared, which solved the uneven pore size distribution in the existing technology. The problems of insufficient hydrophilicity and poor antibacterial performance have significantly improved the filtration efficiency and blood transfusion safety.
Patent Information
- Application Number
- CN202411137839.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-12
AI Technical Summary
The existing deletion leukocyte filtration membranes have uneven pore size distribution, insufficient hydrophilicity and poor antibacterial performance, resulting in a reduced level of leukocyte filtration, a reduced red blood cell recovery rate, and a threat to blood transfusion safety.
Using electrospinning technology combined with chitosan and polybutylene terephthalate, a high-precision leukocyte-deletion filter membrane with uniform pore size distribution and hydrophilicity and natural antibacterial effects was prepared, eliminating hydrophilic modification. enhances mechanical strength and thermal stability.
A highly uniform filter membrane is achieved, which significantly improves the leukocyte filtration efficiency and red blood cell recovery rate, reduces the free hemoglobin content, ensures biocompatibility and antibacterial performance, and improves blood transfusion safety.
Smart Images

Figure CN118925511A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of filter membrane preparation, and in particular to a high-precision leukocyte-removing filter membrane and a preparation method thereof. Background Art
[0002] In modern medicine, blood transfusion therapy is an important means of treating a variety of clinical conditions such as surgery, trauma, and blood diseases. However, the blood transfusion process may be accompanied by risks such as non-hemolytic transfusion reactions, which are often related to the residual white blood cells in the transfused blood. In order to reduce these adverse reactions and improve the safety of blood transfusion, white blood cell filtration technology came into being.
[0003] Existing leukocyte removal technologies mainly include physical filtration, adsorption and centrifugation. Among them, physical filtration technology uses the pore size screening effect of the filter medium to remove white blood cells from the blood, which has been proven by the market to be the most economical and efficient technical means at this stage. The filter medium of physical filtration technology is usually composed of polyester fiber non-woven fabrics, polyolefin non-woven fabrics or glass fiber membranes. Although it can effectively separate white blood cells through pore size structure and material properties, there are still a series of unresolved technical problems.
[0004] First, the overall filtration performance of the filter is greatly affected by the uniformity of the pore size distribution of the filter medium. Too wide a pore size distribution will lead to lower white blood cell removal levels and lower red blood cell recovery rates; secondly, the most commonly used polyester filter membranes are not hydrophilic in themselves. In order to improve blood biocompatibility, they are usually subjected to secondary hydrophilic treatment. These treatments cannot completely avoid the risk of hydrophilic groups falling off; finally, in order to ensure the safety of blood transfusion, the filters are usually sterilized after assembly, including high-pressure steam extinction or ethylene oxide sterilization. However, since the filter medium itself does not have antibacterial properties, these treatments cannot guarantee that the filters will not breed bacteria again during storage and transportation, thereby causing potential blood transfusion safety issues.
[0005] Therefore, we proposed a high-precision leukocyte-removing filtration membrane with highly uniform pore size distribution, hydrophilicity and antibacterial properties, and a preparation method thereof. Summary of the invention
[0006] In view of the shortcomings of the background technology, the present invention provides a method for preparing a high-precision leukocyte-removing filter membrane. The natural hydrophilicity and antibacterial properties of chitosan are combined with the physical stability of polybutylene terephthalate, and a leukocyte-removing filter membrane with uniform pore size distribution, hydrophilicity and natural antibacterial effect is accurately prepared through electrospinning technology. The hydrophilic modification treatment step of conventional technology is omitted, and potential dangers such as the shedding of modified substances are avoided. At the same time, the addition of natural antibacterial chitosan provides more protection for blood transfusion safety, and the addition of polybutylene terephthalate contributes to the necessary mechanical strength and thermal stability, so that the leukocyte-removing filter membrane has good durability and reliability while maintaining a high degree of hydrophilicity.
[0007] A method for preparing a high-precision leukocyte-removing filter membrane comprises the following steps:
[0008] S1: Preparation of spinning solution
[0009] A chitosan solution is prepared by using chitosan and acetic acid, a polybutylene terephthalate solution is prepared by using polybutylene terephthalate and hexafluoroisopropanol, and the chitosan solution and the polybutylene terephthalate solution are mixed to obtain a spinning solution;
[0010] S2: Preparation of leukocyte-removal membrane
[0011] The spinning solution is prepared by an electrostatic spinning process to obtain a filter membrane, and the filter membrane is subjected to heat treatment to obtain a spinning solution.
[0012] Furthermore, step S1 prepares the spinning solution, which specifically includes the following steps:
[0013] S1.1: adding chitosan to a 60% acetic acid solution, stirring and dissolving the chitosan under magnetic stirring at 300-500 r / min for 10-20 min to obtain a chitosan solution;
[0014] S1.2: adding polybutylene terephthalate to hexafluoroisopropanol, stirring and dissolving the polybutylene terephthalate under magnetic stirring at 300-500 r / min for 10-20 min to obtain a polybutylene terephthalate solution;
[0015] S1.3: The chitosan solution and the polybutylene terephthalate solution are mixed under mechanical stirring at 200-300 r / min for 10-20 min to obtain a spinning solution.
[0016] Furthermore, step S2, preparation of the leukocyte-removing filter membrane, specifically comprises the following steps:
[0017] S2.1: Select a stainless steel spinneret to inject the spinning solution, select a flat plate receiver as a receiving device for the filter membrane, and prepare the filter membrane through an electrospinning process;
[0018] S2.2: The prepared filter membrane is heat-treated to obtain a leukocyte-removing filter membrane.
[0019] Furthermore, in step S1.1, the mixing ratio of chitosan to acetic acid solution is 1-2:10-20.
[0020] Furthermore, in step S1.2, the mixing ratio of polybutylene terephthalate to hexafluoroisopropanol is 1-2:16-32.
[0021] Furthermore, in step S1.3, the mixing ratio of the chitosan solution to the polybutylene terephthalate solution is 1:1-50.
[0022] Furthermore, in step S2.1, the inner diameter of the stainless steel spinneret is 0.5-0.7 mm, the electrospinning parameters are a spinning voltage of 10-30 kV, a flow rate of the syringe pump of 0.1-1 mL / h, and the distance between the receiver and the spinneret is controlled to be 15-30 cm.
[0023] Furthermore, in step S2.1, the electrospinning parameters are as follows: the spinning voltage is 25 kV, the flow rate of the syringe pump is 0.5 mL / h, and the distance between the receiver and the spinneret is controlled to be 15 cm.
[0024] Furthermore, the heat treatment conditions in step S2.2 are: temperature 40-100° C., time 5-24 h.
[0025] A high-precision leukocyte-removing filter membrane is obtained by the preparation method of the high-precision leukocyte-removing filter membrane.
[0026] Compared with the prior art, the present invention has at least the following beneficial effects:
[0027] 1. The present invention uses chitosan and polybutylene terephthalate as raw materials, accurately controls the spinning parameters, and prepares a leukocyte-removing filter membrane with highly uniform pore size. The pore size distribution is stably controlled at 8.0±1.5μm, and the pore size of 8.0μm accounts for about 99%. Therefore, the pore size of the prepared leukocyte-removing filter membrane is highly uniform. At the same time, since the pore size of the leukocyte-removing filter membrane is highly uniform, it has good hydrophilicity and biocompatibility, can filter out the remaining white blood cells to the 4log level, and maintain a red blood cell recovery rate of about 95%, as well as a free hemoglobin content far below the industry standard, and has excellent filtration performance.
[0028] 2. The present invention prepares a leukocyte-removing filter membrane by using chitosan and polybutylene terephthalate. Chitosan has good biocompatibility and little irritation to human tissue, thus providing safety guarantee for the application of the leukocyte-removing filter membrane in the medical field. In addition, chitosan has an inhibitory effect on a variety of bacteria and fungi, thus effectively preventing the infection problems caused by bacterial growth during the use, storage and transportation of the leukocyte-removing filter membrane, thus keeping the leukocyte-removing filter membrane clean and hygienic. The added polybutylene terephthalate has high strength and high toughness, thus being able to withstand the pressure and impact force during the filtration process, and not being easily broken or damaged, thus ensuring the stability and reliability of the leukocyte-removing filter membrane. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] The accompanying drawings, which are incorporated herein and constitute a part of the specification, illustrate embodiments of the present disclosure and, together with the description, further serve to explain the principles of the present disclosure and to enable those skilled in the relevant art to make and use the present disclosure.
[0030] Figure 1 A flow chart of a method for preparing a high-precision leukocyte-removing filter membrane used in an embodiment of the present invention;
[0031] Figure 2 is the SEM image of Example 1 of the present invention;
[0032] Figure 3 is the SEM image of Example 2 of the present invention;
[0033] Figure 4 This is the SEM image of Example 3 of the present invention;
[0034] Figure 5 The pore size distribution result of the leukocyte-removing filter membrane in Example 1 of the present invention;
[0035] Figure 6 The pore size distribution result of the leukocyte-removing filter membrane of Example 2 of the present invention;
[0036] Figure 7 The pore size distribution result of the leukocyte-removing filter membrane of Example 3 of the present invention;
[0037] Figure 8 The antibacterial performance test results of Examples 1-3 of the present invention are shown. DETAILED DESCRIPTION
[0038] The following is a detailed description of a high-precision leukocyte-removing filter membrane and a preparation method thereof provided by the present invention in conjunction with the accompanying drawings and specific embodiments. At the same time, it is explained here that in order to make the embodiments more detailed, the following embodiments are the best and preferred embodiments, and those skilled in the art may also adopt other alternative methods to implement some known technologies; and the accompanying drawings are only for a more specific description of the embodiments, and are not intended to specifically limit the present invention.
[0039] Example 1
[0040] A method for preparing a high-precision leukocyte-removing filter membrane, such as Figure 1 As shown, the following steps are included:
[0041] S1: Preparation of spinning solution
[0042] S1.1: Add 6 parts by weight of chitosan to 75 parts by weight of 60% acetic acid solution, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a chitosan solution;
[0043] S1.2: Add 6 parts by weight of polybutylene terephthalate to 120 parts by weight of hexafluoroisopropanol, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a polybutylene terephthalate solution;
[0044] S1.3: mixing 1 part by weight of chitosan solution and 5 parts by weight of polybutylene terephthalate solution under mechanical stirring at 200 r / min for 10 min to obtain a spinning solution;
[0045] S2: Preparation of leukocyte-removal membrane
[0046] S2.1: Select a stainless steel spinneret with an inner diameter of 0.5 mm to inject the spinning solution, select a flat receiver as the receiving device of the filter membrane, set the spinning voltage to 25 kV, the flow rate of the injection pump to 0.5 mL / h, control the distance between the receiver and the spinneret to 15 cm, and prepare the filter membrane through the electrospinning process;
[0047] S2.2: Heat-treat the prepared filter membrane at 80°C for 6 hours to obtain a leukocyte-removing filter membrane.
[0048] Example 2
[0049] A method for preparing a high-precision leukocyte-removing filter membrane, such as Figure 1 As shown, the following steps are included:
[0050] S1: Preparation of spinning solution
[0051] S1.1: Add 6 parts by weight of chitosan to 75 parts by weight of 60% acetic acid solution, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a chitosan solution;
[0052] S1.2: Add 6 parts by weight of polybutylene terephthalate to 120 parts by weight of hexafluoroisopropanol, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a polybutylene terephthalate solution;
[0053] S1.3: mixing 1 part by weight of chitosan solution and 3 parts by weight of polybutylene terephthalate solution under mechanical stirring at 200 r / min for 10 min to obtain a spinning solution;
[0054] S2: Preparation of leukocyte-removal membrane
[0055] S2.1: Select a stainless steel spinneret with an inner diameter of 0.5 mm to inject the spinning solution, select a flat receiver as the receiving device of the filter membrane, set the spinning voltage to 25 kV, the flow rate of the injection pump to 0.5 mL / h, control the distance between the receiver and the spinneret to 15 cm, and prepare the filter membrane through the electrospinning process;
[0056] S2.2: Heat-treat the prepared filter membrane at 80°C for 6 hours to obtain a leukocyte-removing filter membrane.
[0057] Example 3
[0058] A method for preparing a high-precision leukocyte-removing filter membrane, such as Figure 1 As shown, the following steps are included:
[0059] S1: Preparation of spinning solution
[0060] S1.1: Add 6 parts by weight of chitosan to 75 parts by weight of 60% acetic acid solution, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a chitosan solution;
[0061] S1.2: Add 6 parts by weight of polybutylene terephthalate to 120 parts by weight of hexafluoroisopropanol, and stir and dissolve for 10 minutes under magnetic stirring at 300 r / min to obtain a polybutylene terephthalate solution;
[0062] S1.3: mixing 1 part by weight of chitosan solution and 1 part by weight of polybutylene terephthalate solution under mechanical stirring at 200 r / min for 10 min to obtain a spinning solution;
[0063] S2: Preparation of leukocyte-removal membrane
[0064] S2.1: Select a stainless steel spinneret with an inner diameter of 0.5 mm to inject the spinning solution, select a flat receiver as the receiving device of the filter membrane, set the spinning voltage to 25 kV, the flow rate of the injection pump to 0.5 mL / h, control the distance between the receiver and the spinneret to 15 cm, and prepare the filter membrane through the electrospinning process;
[0065] S2.2: Heat-treat the prepared filter membrane at 80°C for 6 hours to obtain a leukocyte-removing filter membrane.
[0066] Structural characterization results:
[0067] from Figure 2-4 It can be seen from the SEM image that the fibers of the leukocyte removal filtration membrane are evenly distributed.
[0068] Pore Size Distribution:
[0069] The pore size distribution of leukocyte-removing filtration membrane was tested by bubble pressure method. Figure 5-7 The results show that the pore sizes of Examples 1, 2, and 3 are concentrated around 8.0 μm, and account for about 99%.
[0070] Determination of residual white blood cell count and red blood cell recovery rate:
[0071] The three groups of leukocyte-removing filter membranes prepared in Examples 1, 2 and 3 were loaded into a leukocyte filter, and 400 ml of whole blood was filtered online. The filtration time, plasma volume before and after filtration, number of leukocytes and number of erythrocytes were recorded. The measurement results are shown in Table 1.
[0072] Red blood cell recovery rate (%) = ((P h ×V h ) / (P q ×V q ))×100%;
[0073] Among them, P h The concentration of red blood cells after filtration, P q is the red blood cell concentration before filtration, V h is the volume of plasma after filtration, V q is the plasma volume before filtration.
[0074] Plasma free hemoglobin determination:
[0075] The absorbance change was measured at 450 nm by using the principle that the heme in erythrocyte hemoglobin (Hb) decomposes carbamide peroxide to cause tetramethylbenzidine (TMB) to oxidize and develop color. The Hb content was determined by comparing it with the standard solution. The results are shown in Table 1.
[0076] C Hb =A B / A R ×100, where:
[0077] C Hb - Free hemoglobin content in plasma or blood supernatant, expressed in milligrams per liter (mg / L);
[0078] A B —Average absorbance of samples;
[0079] A R —Average absorbance of standard solution;
[0080] 100—Hemoglobin content of hemoglobin standard solution, in milligrams per liter (mg / L).
[0081] Table 1. Whole blood filtration results and free hemoglobin determination results of Examples 1-3
[0082] Key Metrics Example 1 Example 2 Example 3 <![CDATA[V h (mL)]]> 381 382 387 Filtration time (min) 8.4 7.8 6.4 Remaining WBC (unit) <![CDATA[0.375×10 6 ]]> <![CDATA[0.40×10 6 ]]> <![CDATA[0.25×10 6 ]]> Red blood cell recovery rate (%) 93.083 95.057 96.468 Free hemoglobin (mg / L) 92.307 61.538 53.85
[0083] From the data in Table 1, it can be seen that the leukocyte filtration membrane can filter out the remaining leukocytes to a 4log level, and maintain a red blood cell recovery rate of about 95%, and a free hemoglobin content far below the industry standard.
[0084] Antibacterial performance test:
[0085] Escherichia coli was selected as the target bacteria, and the antibacterial performance test was carried out using the inhibition zone method. The specific experimental method is as follows: Cut the leukocyte filter membranes of Examples 1, 2, and 3 into samples with a diameter of 6 mm, place them on the nutrient agar plate inoculated with Escherichia coli, and take them out after ensuring sufficient contact with the bacteria. Then, place the agar plate in a constant temperature incubator at 37°C and culture for 48 hours. After the culture is completed, take out the plate and observe the inhibition zone formed around the filter membrane. Its diameter directly reflects the antibacterial effect of the filter membrane. The larger the inhibition zone, the stronger the antibacterial performance of the filter membrane. The measurement results can be referred to Figure 8 , wherein a is Example 1, b is Example 2, and c is Example 3.
[0086] from Figure 8 It can be seen that the inhibition zones of Examples 1-3 are all larger than that of the control group, indicating that the leukocyte filtration membrane prepared by the present invention has good antibacterial properties and provides additional safety protection for avoiding infection during blood transfusion.
[0087] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the art may modify or alter the above embodiments without departing from the spirit and scope of the present invention. Therefore, all equivalent modifications or alterations made by a person of ordinary skill in the art without departing from the spirit and technical concept disclosed by the present invention shall still be covered by the claims of the present invention.
Claims
1. A method for preparing a high-precision leukocyte-removing filter membrane. It is characterized in that The steps include: S1: Preparation of spinning solution A chitosan solution is prepared by using chitosan and acetic acid, a polybutylene terephthalate solution is prepared by using polybutylene terephthalate and hexafluoroisopropanol, and the chitosan solution and the polybutylene terephthalate solution are mixed to obtain a spinning solution; S2: Preparation of leukocyte-removing filter membrane The spinning solution is prepared by an electrostatic spinning process to obtain a filter membrane, and the filter membrane is subjected to heat treatment to obtain a spinning solution.
2. A method for preparing a high-precision leukocyte-removing filter membrane according to claim 1, It is characterized in that Step S1 is to prepare a spinning solution, which specifically includes the following steps: S1.1: adding chitosan to a 60% acetic acid solution, stirring and dissolving the chitosan under magnetic stirring at 300-500 r / min for 10-20 min to obtain a chitosan solution; S1.2: adding polybutylene terephthalate to hexafluoroisopropanol, stirring and dissolving the polybutylene terephthalate under magnetic stirring at 300-500 r / min for 10-20 min to obtain a polybutylene terephthalate solution; S1.3: The chitosan solution and the polybutylene terephthalate solution are mixed under mechanical stirring at 200-300 r / min for 10-20 min to obtain a spinning solution.
3. A method for preparing a high-precision leukocyte-removing filter membrane according to claim 2, It is characterized in that Step S2: Preparation of leukocyte-removing filter membrane, specifically comprising the following steps: S2.1: Select a stainless steel spinneret to inject the spinning solution, select a flat plate receiver as a receiving device for the filter membrane, and prepare the filter membrane through an electrospinning process; S2.2: The prepared filter membrane is heat-treated to obtain a leukocyte-removing filter membrane.
4. A method for preparing a high-precision leukocyte-removing filter membrane according to claim 2, It is characterized in that In step S1.1, the mixing ratio of chitosan to acetic acid solution is 1-2:10-20.
5. A method for preparing a high-precision leukocyte-removing filter membrane according to claim 2, It is characterized in that In step S1.2, the mixing ratio of polybutylene terephthalate and hexafluoroisopropanol is 1-2:16-32.
6. A method for preparing a high-precision leukocyte-removing filtration membrane according to claim 2, It is characterized in that In step S1.3, the mixing ratio of the chitosan solution to the polybutylene terephthalate solution is 1:1-50.
7. A method for preparing a high-precision leukocyte-removing filtration membrane according to claim 3, It is characterized in that In step S2.1, the inner diameter of the stainless steel spinneret is 0.5-0.7 mm, the electrospinning parameters are: spinning voltage is 10-30 kV, the flow rate of the syringe pump is 0.1-1 mL / h, and the distance between the receiver and the spinneret is controlled to be 15-30 cm.
8. A method for preparing a high-precision leukocyte-removing filtration membrane according to claim 7, It is characterized in that The electrospinning parameters in step S2.1 are as follows: the spinning voltage is 25 kV, the flow rate of the syringe pump is 0.5 mL / h, and the distance between the receiver and the spinneret is controlled to be 15 cm.
9. The method for preparing a high-precision leukocyte-removing filtration membrane according to claim 3, It is characterized in that The heat treatment conditions in step S2.2 are: temperature 40-100°C, time 5-24h.
10. A high-precision leukocyte removal filter membrane, It is characterized in that The membrane is obtained by the method for preparing a high-precision leukocyte-removing filtration membrane as described in any one of claims 1 to 9.
